- Patients Patients
Reproductive Genetics Testing
Patient Resources
Cost & Billing
- Providers Providers
- Genetic Counseling
- Login Login
- Estimate My Cost
Testing and continuity of care for preconception, pregnancy and pediatric care
Pregnancy is a dynamic time. Whether you’re looking for carrier screening, routine tests or more advanced diagnostic testing, Labcorp is one of the few laboratories that can deliver pregnancy insights while providing a true continuity of care and support throughout the entire pregnancy period and beyond.
Carrier screening can help determine if you and your partner are at an increased risk of having a baby with a specific inherited disorder, such as cystic fibrosis or spinal muscular atrophy. Early insight can help you better prepare for the future.
Labcorp offers choice in carrier screening, from a comprehensive screen for more than 500 disorders to screening for specific disorders. Your doctor can help you determine which test is right for you.
Carrier screening can be performed at any time but is most useful if it is performed before pregnancy or as early as possible during pregnancy.
Routine and regular lab tests are suggested for all women as part of routine prenatal care. These tests can help confirm that you are healthy, as well as provide vital information to help you manage and decrease any risks that your health may pose to your newborn baby. Talk to your doctor about what tests are right for you.
Routine obstetric profiles are suggested in both the first and second trimesters
Gestational diabetes screening is recommended at 24-28 weeks1
By detecting small amounts of DNA from the placenta in your bloodstream, a noninvasive prenatal test (NIPS/NIPT) can help identify if there is an increased chance for certain chromosome abnormalities that can affect your baby’s health and development. It can also indicate if you are more likely to have a boy, girl or both.
Most NIPSs (NIPTs) screen for certain chromosomal abnormalities called trisomies. These include trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome).
NIPS (NIPT) can be performed in any of the trimesters during pregnancy but is typically not performed until after nine weeks to ensure there are enough fetal cells to screen.
Prenatal or maternal serum screening tests are another noninvasive option for determining the chance your baby may have a chromosome abnormality that may affect their development. These screening assays can help to detect Down syndrome, trisomy 18 or open neural tube defects, depending on the particular test your doctor uses and how far along you are in your pregnancy.
Similar to NIPS (NIPT), a positive serum screen can be confirmed with a diagnostic test. Your doctor can help determine which tests are right for you.
Prenatal or maternal serum screening is typically performed in the first and second trimesters, and they may be done with sequential blood samples—one collected in the first trimester and another collected in the second trimester.
Diagnostic procedures, such as amniocentesis and chorionic villus sampling (CVS), are used to perform tests for chromosomal abnormalities, open neural tube defects and/or specific inherited diseases in an ongoing pregnancy.
We also offer pediatric diagnostic testing to analyze chromosomes in newborns and infants for changes that can explain certain birth defects or developmental delays.
Prenatal diagnostic testing is not a routine test during pregnancy but can be considered or recommended by your physician when clinically indicated, such as in the case of a positive NIPS (NIPT) or prenatal/maternal serum screening result. CVS specimens are generally collected at nine weeks or later, and amniotic fluid samples are not recommended to be collected before 15 weeks.